Jefferies upgraded Rigel Pharmaceuticals (RIGL) to Buy from Hold with a $42 price target
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RIGL:
- Midday Fly By: Broader market bought on dip after tech selloff
- Rigel Pharmaceuticals price target raised to $38 from $32 at Cantor Fitzgerald
- Rigel Pharmaceuticals Reports Strong Q3 2025 Results
- Rigel Pharmaceuticals reports Q3 EPS $1.46, consensus 94c
- Rigel Pharmaceuticals raises FY25 revenue view to $285M-$290M from $270M-$280M